view all news
Complete Story
OSMA has joined the AMA and other medical, public health, and community organizations in filing an amicus brief in the United States Court of Appeals for the Sixth Circuit in support of the Federal Drug Administration’s (FDA) decision to deny a marketing approval request by Breeze Smoke, a provider of flavored, disposable e-cigarettes.
Complete Story
12/19/2021
OSMA Joins Amicus Brief in E-cigarettes Case
Breeze Smoke v FDA
OSMA has joined the AMA and other medical, public health, and community organizations in filing an amicus brief in the United States Court of Appeals for the Sixth Circuit in support of the Federal Drug Administration’s (FDA) decision to deny a marketing approval request by Breeze Smoke, a provider of flavored, disposable e-cigarettes.
We're urging the court to uphold the FDA’s Final Marketing Denial Order because their decision was supported by evidence showing that the harm to the public, especially youth, was greater than the evidence provided by the company that their flavored nicotine product assisted smoking cessation more than unflavored products.
Medical groups support the FDA’s denial as it protects the public, including minors, from marketing that entices use of electronic tobacco products without appreciation of the harm they cause. Both OSMA and the AMA consistently advocate against tobacco use and have policy against use of e-cigarettes and electronic nicotine delivery system (ENDS) devices, especially flavored nicotine products.
